Literature DB >> 11810090

Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus.

Makrina D Savvidou1, Lut Geerts, Kypros H Nicolaides.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the vascular function of pregnant women with insulin-dependent diabetes mellitus, using a noninvasive method. STUDY
DESIGN: This was a cross-sectional study that examined vascular function, which was assessed by flow-mediated dilatation of the brachial artery, in 37 pregnant women with insulin-dependent diabetes mellitus and in 37 healthy pregnant women at 20 weeks of gestation. The control of diabetes was also assessed by the measurement of glycosylated hemoglobin. Data were analyzed by 2-sided unpaired t test and multivariate regression analysis.
RESULTS: In the pregnant women with insulin-dependent diabetes mellitus, flow-mediated dilatation of the brachial artery was significantly lower than in healthy pregnant women (6.43% +/- 3.66% vs 9.43% +/- 3.69%, respectively; P =.0008). This difference was apparent even after an adjustment was made for blood vessel diameter, which was different between the 2 populations (P =.01). Flow-mediated dilatation in diabetic women was significantly correlated with the duration of diabetes (P =.01) but not with the levels of glycosylated hemoglobin.
CONCLUSION: Maternal insulin-dependent diabetes mellitus is associated with an impaired vasodilatory response to a blood flow stimulus. This vascular dysfunction is associated with the duration of the diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11810090     DOI: 10.1067/mob.2002.119111

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

1.  Experimental gestational diabetes mellitus induces blunted vasoconstriction and functional changes in the rat aorta.

Authors:  Cecilia Tufiño; Cleva Villanueva-López; Maximiliano Ibarra-Barajas; Ismael Bracho-Valdés; Rosa Amalia Bobadilla-Lugo
Journal:  Biomed Res Int       Date:  2014-12-28       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.